Colorectal Cancer Patient Recruitment in Wisconsin

TheraNovex connects clinical trial sponsors with pre-screened, eligible Colorectal Cancer patients across Wisconsin, including Milwaukee, Madison, Green Bay, and beyond.

Colorectal cancer patient recruitment for clinical trials targeting MSI-H, KRAS, BRAF, and other molecular subtypes.

Who qualifies: Adults with Stage II–IV colorectal cancer, including MSI-H/dMMR and RAS/RAF wild-type patients.

Recruitment challenges: Molecular subtype eligibility and prior chemotherapy requirements create narrow enrollment windows.

Our approach: GI oncology referral networks, patient advocacy partnerships, and biomarker-guided pre-screening protocols.

Our recruitment network spans all major metropolitan areas in Wisconsin, ensuring broad geographic coverage for your Colorectal Cancer trial.